RIYADH – Dr. Khalid Al-Sahli, a member of the Medical Services Department at the Ministry of Interior and a member of the comprehensive clinics of the Security Forces in Jazan, in his findings set a new scientific achievement that has perked the interest of a pharmaceutical company.

Dr. Khalid set a new achievement by first discovering a new brand of protein that could stimulate the occurrence of strokes, and then finding an antidote to it by designing a compound that reduces clotting that could trigger a stroke, Saudi Press Agency (SPA) said Friday.

Dr. Khalid discovered that the protein forms in channels of communication between platelets. Then, it helps adhesion of platelets and the occurrence of clots by the transfer of some of these platelets to stimulate occurrence of strokes.

During the course of his doctoral study, Dr. Khalid succeeded in designing a compound that for the first time prevented the occurrence of such a contact, in the clotting process. He carried out research, both on humans and animals, and it was found that the compound has the ability to reduce the size of clots to about 65 to 75%.

The British Heart Association and a pharmaceutical company are seeking to collaborate with him, for further research related to his findings. — SPA